WO1993000057A1 - Transdermal nicotine absorption dosage unit and process - Google Patents

Transdermal nicotine absorption dosage unit and process Download PDF

Info

Publication number
WO1993000057A1
WO1993000057A1 PCT/US1992/005271 US9205271W WO9300057A1 WO 1993000057 A1 WO1993000057 A1 WO 1993000057A1 US 9205271 W US9205271 W US 9205271W WO 9300057 A1 WO9300057 A1 WO 9300057A1
Authority
WO
WIPO (PCT)
Prior art keywords
nicotine
dosage unit
transdermal
layer
skin
Prior art date
Application number
PCT/US1992/005271
Other languages
English (en)
French (fr)
Inventor
Chin-Chih Chiang
Jhili Wu
Original Assignee
Tbs Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tbs Laboratories, Inc. filed Critical Tbs Laboratories, Inc.
Publication of WO1993000057A1 publication Critical patent/WO1993000057A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PCT/US1992/005271 1991-06-26 1992-06-24 Transdermal nicotine absorption dosage unit and process WO1993000057A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72112991A 1991-06-26 1991-06-26
US721,129 1991-06-26

Publications (1)

Publication Number Publication Date
WO1993000057A1 true WO1993000057A1 (en) 1993-01-07

Family

ID=24896654

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/005271 WO1993000057A1 (en) 1991-06-26 1992-06-24 Transdermal nicotine absorption dosage unit and process

Country Status (6)

Country Link
EP (1) EP0544900A4 (ja)
CN (1) CN1067811A (ja)
AU (1) AU2294192A (ja)
CA (1) CA2094913A1 (ja)
TW (1) TW221970B (ja)
WO (1) WO1993000057A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5603947A (en) * 1993-07-09 1997-02-18 Cygnus Terapeutic Systems Method and device for providing nicotine replacement therapy transdermally/transbuccally
US20060286160A1 (en) * 2005-06-21 2006-12-21 Shiro Satoda Nicotine transdermal delivery system
EP1774964A1 (en) * 2005-10-13 2007-04-18 Nitto Denko Corporation Nicotine transdermal preparation and production method thereof
WO2011120704A1 (en) * 2010-03-31 2011-10-06 Hexal Ag Transdermal patch containing 17-deacetyl norgestimate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672888A5 (ja) * 1986-11-07 1990-01-15 Mepha Ag
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0544900A4 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5603947A (en) * 1993-07-09 1997-02-18 Cygnus Terapeutic Systems Method and device for providing nicotine replacement therapy transdermally/transbuccally
US20060286160A1 (en) * 2005-06-21 2006-12-21 Shiro Satoda Nicotine transdermal delivery system
EP1736146A1 (en) * 2005-06-21 2006-12-27 Nitto Denko Corporation Nicotine transdermal delivery system
JP2007031427A (ja) * 2005-06-21 2007-02-08 Nitto Denko Corp ニコチン含有経皮吸収製剤
TWI412380B (zh) * 2005-06-21 2013-10-21 Nitto Denko Corp 尼古丁經皮傳輸系統
EP1774964A1 (en) * 2005-10-13 2007-04-18 Nitto Denko Corporation Nicotine transdermal preparation and production method thereof
TWI383794B (zh) * 2005-10-13 2013-02-01 Nitto Denko Corp 尼古丁經皮吸收製劑及其製造方法
US8506991B2 (en) 2005-10-13 2013-08-13 Nitto Denko Corporation Nicotine transdermal preparation and production method thereof
KR101317053B1 (ko) * 2005-10-13 2013-10-11 닛토덴코 가부시키가이샤 니코틴 경피 제제 및 이의 제조 방법
WO2011120704A1 (en) * 2010-03-31 2011-10-06 Hexal Ag Transdermal patch containing 17-deacetyl norgestimate
EP2377540A1 (en) * 2010-03-31 2011-10-19 Hexal AG Transdermal patch containing 17-deacetyl norgestimate

Also Published As

Publication number Publication date
CN1067811A (zh) 1993-01-13
TW221970B (ja) 1994-04-01
EP0544900A1 (en) 1993-06-09
EP0544900A4 (en) 1993-12-01
AU2294192A (en) 1993-01-25
CA2094913A1 (en) 1992-12-27

Similar Documents

Publication Publication Date Title
JP3021661B2 (ja) 薬剤含有接着複合体の経皮放出デバイス
US5145682A (en) Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US5560922A (en) Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
DK175580B1 (da) Transdermal absorptionsdosisenhed til narkotiske analgetika og antagonister
US5230896A (en) Transdermal nicotine delivery system
CA2135925C (en) Use of glycerin in moderating transdermal drug delivery
EP1585470B1 (en) Transdermal delivery of fentanyl
CA2550704C (en) Nicotine transdermal delivery system
MXPA96003667A (en) Composed transdermal supply device adhesive containing dr
KR20010036685A (ko) 펜타닐을 함유하는 매트릭스형 경피투여제
NZ200903A (en) Transdermal administration of a drug from a bandage
CZ287053B6 (en) Transdermal therapeutic system for application galanthamine to skin
EP0371496A1 (en) Compositions for transdermal delivery of estradiol
US20060088580A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion
CA2387143C (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
WO1993000057A1 (en) Transdermal nicotine absorption dosage unit and process
WO2017089361A1 (en) Transdermal patches
AU6141090A (en) Transdermal nitroglycerin patch with penetration enhancers
US20030175330A1 (en) Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
PL172999B1 (pl) Terapeutyczny system przezskórny (TTS) do podawania fizostygminy na skórę i sposób wytwarzania terapeutycznego systemu przezskórnego do podawania fizostygminy na skórę
WO1993019708A1 (en) Transdermal albuterol absorption dosage unit and process

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA FI JP KR NO RU

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

WWE Wipo information: entry into national phase

Ref document number: 1992915353

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2094913

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1992915353

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1992915353

Country of ref document: EP